Interestingly, alteration in sphingolipid signaling axis, as manifested by increased levels of ceramides S1P and S1P synthesizing enzyme, sphingosine kinase 1 (SPHK1), was observed in lung and tracheal aspirates of BPD patients [29,30,41]. The gene discussed is SPHK1; the disease is bronchopulmonary dysplasia.